SCHEMBL13692807

SCHEMBL13692807

CN1CC(c2ccc3ncc(C(O)c4ccc5nccnc5c4)n3n2)C=N1

nearest known ligand 0.39

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
MET P08581 3/20 0.39
OGA O60502 17/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13692815 0.89 MET (0.52) MET
SCHEMBL13692929 0.89 MET (0.52) MET
SCHEMBL13692842 0.82 MET (0.35) MET
SCHEMBL13692954 0.81 MET (0.42) MET
SCHEMBL13692828 0.79 MET (0.51) MET
SCHEMBL13692944 0.76 MET (0.33) MET
SCHEMBL4513787 0.75 FYN (0.53) METOGA
SCHEMBL3407568 0.74 MET (0.44) METOGA
SCHEMBL13692893 0.66 MET (0.35) MET
SCHEMBL13692779 0.66 MET (0.41) MET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009106577-A1 IMIDAZO [1,2-B] PYRIDAZINE DERIVATIVES FOR THE TREATMENT OF C-MET TYROSINE KINASE MEDIATED DISEASE NOVARTIS AG (CH) 2009-09-03 WO disclosed